KOD — Kodiak Sciences Cashflow Statement
0.000.00%
- $1.03bn
- $926.39m
Annual cashflow statement for Kodiak Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -133 | -267 | -334 | -260 | -176 |
| Depreciation | |||||
| Non-Cash Items | 30.7 | 69.3 | 112 | 95.4 | 68.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 18.5 | 14.4 | 12 | -7.36 | -28.4 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -83.4 | -182 | -206 | -154 | -117 |
| Capital Expenditures | -7 | -63.3 | -47.4 | -41.4 | -0.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 112 | 24.5 | -289 | 291 | -0.355 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 105 | -38.8 | -337 | 249 | -0.755 |
| Financing Cash Flow Items | 99.1 | -0.045 | -0.049 | -0.211 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 717 | 8.18 | 1.9 | 0.031 | 0.501 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 739 | -213 | -541 | 95.1 | -118 |